0001213900-19-001171.txt : 20190124
0001213900-19-001171.hdr.sgml : 20190124
20190124170039
ACCESSION NUMBER: 0001213900-19-001171
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190124
DATE AS OF CHANGE: 20190124
EFFECTIVENESS DATE: 20190124
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kitov Pharma Ltd.
CENTRAL INDEX KEY: 0001614744
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-331330
FILM NUMBER: 19540534
BUSINESS ADDRESS:
STREET 1: ONE AZRIELI CENTER, ROUND TOWER
STREET 2: 132 MENACHEM BEGIN ROAD
CITY: TEL AVIV
STATE: L3
ZIP: 6701101
BUSINESS PHONE: 97239333121
MAIL ADDRESS:
STREET 1: ONE AZRIELI CENTER, ROUND TOWER
STREET 2: 132 MENACHEM BEGIN ROAD
CITY: TEL AVIV
STATE: L3
ZIP: 6701101
FORMER COMPANY:
FORMER CONFORMED NAME: Kitov Pharmaceuticals Holdings Ltd.
DATE OF NAME CHANGE: 20140724
D
1
primary_doc.xml
X0708
D
LIVE
0001614744
Kitov Pharma Ltd.
ONE AZRIELI CENTER
ROUND TOWER
TEL AVIV
L3
ISRAEL
6701101
97239333121
ISRAEL
Mainrom Line Logistics Ltd.
Kitov Pharmaceuticals Holdings Ltd.
Other
Limited company
true
Isaac
Israel
One Azrieli Center
Round Building
Tel Aviv
L3
ISRAEL
6701101
Executive Officer
Director
Chief Executive Officer and Director of the Issuer
John Paul
Waymack
One Azrieli Center
Round Building
Tel Aviv
L3
ISRAEL
6701101
Executive Officer
Director
Chief Medical Officer and Chairman of the Board of Directors of the Issuer
Simcha
Rock
One Azrieli Center
Round Building
Tel Aviv
L3
ISRAEL
6701101
Director
Director of the Issuer
Steven
Steinberg
One Azrieli Center
Round Building
Tel Aviv
L3
ISRAEL
6701101
Director
Independent Director of the Issuer
Ido
Agmon
One Azrieli Center
Round Building
Tel Aviv
L3
ISRAEL
6701101
Director
Independent Director of the Issuer
Arye
Weber
One Azrieli Center
Round Building
Tel Aviv
L3
ISRAEL
6701101
Director
Independent Director of the Issuer
Ran
Tzror
One Azrieli Center
Round Building
Tel Aviv
L3
ISRAEL
6701101
Director
Independent Director of the Issuer
Revital
Stern-Raff
One Azrieli Center
Round Building
Tel Aviv
L3
ISRAEL
6701101
Director
Independent Director of the Issuer
Gil
Ben-Menachem
One Azrieli Center
Round Building
Tel Aviv
L3
ISRAEL
6701101
Executive Officer
Director
Vice President of Business Development and Director of the Issuer
Hadas
Reuveni
One Azrieli Center
Round Building
Tel Aviv
L3
ISRAEL
6701101
Executive Officer
Founder and Chief Technology Officer of TyrNovo, a subsidiary of the Issuer
Gil
Efron
One Azrieli Center
Round Building
Tel Aviv
L3
ISRAEL
6701101
Executive Officer
Deputy CEO and Chief Financial Officer of the Issuer
Pharmaceuticals
Decline to Disclose
- 06b
false
2019-01-18
false
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 PARK AVENUE
3RD FLOOR
NEW YORK
NY
NEW YORK
10022
NJ
NEW JERSEY
NY
NEW YORK
false
6000001
6000001
0
Represents the aggregate amount received from investors in connection with Issuer's registered offering of ADSs and concurrent private placement of warrants, respectively, which were issued jointly to investors for a single purchase price.
false
2
420000
true
0
Represents 6% commission and 1% management fee of gross proceeds from investors for sale of ADSs in the registered offering and concurrent private placement of warrants. We also paid or reimbursed expenses of $80,000 and issued an unregistered warrant.
0
false
Kitov Pharma Ltd.
/s/ Gil Efron
Gil Efron
Deputy CEO and Chief Financial Officer
2019-01-24